Immunohistochemical Expression of Ki-67 to Predict Lymph Node Involvement in Clinical Stage I Nonseminomatous Germ Cell Tumors-Reference-Cited by-同舟云学术

Immunohistochemical Expression of Ki-67 to Predict Lymph Node Involvement in Clinical Stage I Nonseminomatous Germ Cell Tumors

Published:1997-08 Issue:2 Volume:158 Page:620-625
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Heidenreich Axel,Schenkmann Noah S.,Sesterhenn Isabell A.,Mostofi F. Kash,McCarthy William F.,Heidenreich Birgit,Moul Judd W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Primary retroperitoneal lymph node dissection in clinical stage A nonseminomatous germ cell testis cancer.;Donohue;Br. J. Urol.,1993

2. Orchiectomy alone in testicular stage I nonseminomatous germ cell tumors.;Peckham;Lancet,1982

3. Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.;Culine;J. Urol.,1996

4. Percentage of embryonal carcinoma and vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.;Moul;Cancer Res.,1994

5. Prognosis and other clinical correlates of pathologic review in stage I and stage II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.;Sesterhenn;J. Clin. Oncol.,1992

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications;Life;2024-02-16

2. Contribution of whole slide imaging‐based deep learning in the assessment of intraoperative and postoperative sections in neuropathology;Brain Pathology;2023-04-25

3. Clinicopathological Significance of DNA Replication Licensing Factors in Head and Neck Diffuse Large B-cell Lymphoma;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2021-11

4. Treatment of clinical stage I non-seminoma;Asian Journal of Urology;2021-04

5. Prognostic and predictive factors in testicular cancer;EUR REV MED PHARMACO;2019